Engineering vascular networks in porous polymer matrices

被引:158
作者
Peters, MC
Polverini, PJ
Mooney, DJ
机构
[1] Univ Michigan, Dept Biomed Engn, Dent Sch 5213, Ann Arbor, MI 48109 USA
[2] Univ Minnesota, Sch Dent, Minneapolis, MN 55455 USA
[3] Univ Michigan, Dept Biol & Mat Sci, Dent Sch 5213, Ann Arbor, MI 48109 USA
[4] Univ Michigan, Dept Chem Engn, Dent Sch 5213, Ann Arbor, MI 48109 USA
来源
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH | 2002年 / 60卷 / 04期
关键词
angiogenesis; drug delivery; endothelial cells; tissue engineering; VEGF;
D O I
10.1002/jbm.10134
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Enhanced vascularization is critical to the treatment of ischemic tissues and the engineering of new tissues and organs. We have investigated whether sustained and localized delivery of vascular endothelial growth factor (VEGF) combined with transplantation of human microvascular endothelial cells (HMVECs) can be used to engineer new vascular networks. VEGF was incorporated and released in a sustained manner from porous poly(lactic-co-glycolic acid) (PLG) matrices to promote angiogenesis at the transplantation site. VEGF could be incorporated and released in a biologically active form from PLG matrices with the majority of VEGF release (64%) occurring within 2 weeks. These matrices promoted a 260% increase in the density of host SCID mouse-derived capillaries invading the matrices after 7 days of implantation, confirming the activity of the released VEGF. HMVECs were transplanted into SCID mice on PLG matrices, and organized to form immature human-derived vessels within 3 days. Functional vessels were observed within 7 days. Importantly, when HMVECs were transplanted on VEGF-releasing matrices, a 160% increase in the density of human-derived blood vessels was observed after 14 days. These findings suggest that combining elements of vasculogenesis and angiogenesis provides a viable and novel approach to enhancing local vascularization. (C) 2002 Wiley Periodicals, Inc.
引用
收藏
页码:668 / 678
页数:11
相关论文
共 40 条
  • [1] ENHANCED ANGIOGENESIS AND GROWTH OF COLLATERALS BY INVIVO ADMINISTRATION OF RECOMBINANT BASIC FIBROBLAST GROWTH-FACTOR IN A RABBIT MODEL OF ACUTE LOWER-LIMB ISCHEMIA - DOSE-RESPONSE EFFECT OF BASIC FIBROBLAST GROWTH-FACTOR
    BAFFOUR, R
    BERMAN, J
    GARB, JL
    RHEE, SW
    KAUFMAN, J
    FRIEDMANN, P
    [J]. JOURNAL OF VASCULAR SURGERY, 1992, 16 (02) : 181 - 191
  • [2] ANGIOGENIC-INDUCED ENHANCEMENT OF COLLATERAL BLOOD-FLOW TO ISCHEMIC MYOCARDIUM BY VASCULAR ENDOTHELIAL GROWTH-FACTOR IN DOGS
    BANAI, S
    JAKLITSCH, MT
    SHOU, M
    LAZAROUS, DF
    SCHEINOWITZ, M
    BIRO, S
    EPSTEIN, SE
    UNGER, EF
    [J]. CIRCULATION, 1994, 89 (05) : 2183 - 2189
  • [3] Baumgartner I, 1998, VASA-J VASCULAR DIS, V27, P201
  • [4] SITE-SPECIFIC THERAPEUTIC ANGIOGENESIS AFTER SYSTEMIC ADMINISTRATION OF VASCULAR ENDOTHELIAL GROWTH-FACTOR
    BAUTERS, C
    ASAHARA, T
    ZHENG, LP
    TAKESHITA, S
    BUNTING, S
    FERRARA, N
    SYMES, JF
    ISNER, JM
    [J]. JOURNAL OF VASCULAR SURGERY, 1995, 21 (02) : 314 - 325
  • [5] CLELAND JL, 1993, CRIT REV THER DRUG, V10, P307
  • [6] IMPLANTABLE BIOHYBRID ARTIFICIAL ORGANS
    COLTON, CK
    [J]. CELL TRANSPLANTATION, 1995, 4 (04) : 415 - 436
  • [7] Blood vessel maturation: Vascular development comes of age
    Darland, DC
    D'Amore, PA
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (02) : 157 - 158
  • [8] FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182
  • [9] Folkman J, 1997, EXS, V79, P1
  • [10] Harris LD, 1998, J BIOMED MATER RES, V42, P396, DOI 10.1002/(SICI)1097-4636(19981205)42:3<396::AID-JBM7>3.3.CO